Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Enoxaparin Versus Aspirin in Patients With Cancer and Stroke

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
New York Presbyterian Hospital
Weill Medical College of Cornell University
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center
ClinicalTrials.gov Identifier:
NCT01763606
First received: December 20, 2012
Last updated: October 6, 2016
Last verified: October 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2018
  Estimated Primary Completion Date: December 2018 (Final data collection date for primary outcome measure)